In a study by Zhang et al. in 2015, inhibition of B7-H3 expression in mantle cell lymphoma by Bendamustine (Ben) and Rituximab (R) was suggested as a primary treatment for mantle cell lymphoma [96]. The gene discussed is CD276; the disease is mantle cell lymphoma.